We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$2.6B
AUM Growth
+$351M
Cap. Flow
+$870M
Cap. Flow %
33.44%
Top 10 Hldgs %
12.89%
Holding
1,330
New
552
Increased
277
Reduced
191
Closed
296

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$32M
2
PAGP icon
Plains GP Holdings
PAGP
+$26.5M
3
FDX icon
FedEx
FDX
+$25.2M
4
BA icon
Boeing
BA
+$25.1M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$24.3M

Top Sells

Rank Stock Value
1
FTV icon
Fortive
FTV
+$26.5M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$21.1M
3
CCC.U
Churchill Capital Corp
CCC.U
+$20.3M
4
IFF icon
International Flavors & Fragrances
IFF
+$16.3M
5
ECYT
Endocyte, Inc. Common Stock
ECYT
+$14.6M

Sector Composition

Rank Sector Weight
1 Healthcare 18.41%
2 Industrials 14.41%
3 Consumer Discretionary 13.15%
4 Technology 10.64%
5 Financials 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LAB icon
76
Standard BioTools
LAB
$345M
$8.24M 0.32%
955,700
+530,300
+125% +$4.13M
REGN icon
77
Regeneron Pharmaceuticals
REGN
$76.2B
$8.08M 0.31%
21,644
+19,144
+766% +$7.01M
V icon
78
Visa
V
$678B
$8.06M 0.31%
61,115
+21,759
+55% +$3.01M
ARMK icon
79
Aramark
ARMK
$15B
$8.01M 0.31%
382,814
+180,742
+89% +$4.69M
DNKN
80
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$7.93M 0.3%
+123,678
New +$8.79M
DE icon
81
Deere & Co
DE
$160B
$7.73M 0.3%
51,800
-39,700
-43% -$5.81M
VRTX icon
82
Vertex Pharmaceuticals
VRTX
$119B
$7.69M 0.3%
46,391
+22,591
+95% +$3.91M
CCK icon
83
Crown Holdings
CCK
$12.7B
$7.53M 0.29%
181,100
+77,900
+75% +$3.6M
SYK icon
84
Stryker
SYK
$123B
$7.42M 0.29%
47,347
+32,347
+216% +$5.41M
NBIX icon
85
Neurocrine Biosciences
NBIX
$16.7B
$7.41M 0.29%
103,789
+53,789
+108% +$5.15M
GWPH
86
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$7.37M 0.28%
75,700
-5,000
-6% -$656K
CVS icon
87
CVS Health
CVS
$133B
$7.25M 0.28%
+110,594
New +$8.26M
NOMD icon
88
Nomad Foods
NOMD
$1.7B
$7.24M 0.28%
433,000
+304,900
+238% +$5.8M
BBWI icon
89
Bath & Body Works
BBWI
$3.99B
$7.18M 0.28%
346,113
+238,618
+222% +$6.01M
PZZA icon
90
Papa John's
PZZA
$985M
$7.16M 0.28%
179,773
+117,373
+188% +$5.92M
PRMW
91
DELISTED
Primo Water Corporation
PRMW
$7.13M 0.27%
511,800
+92,300
+22% +$1.36M
BHVN
92
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$7.12M 0.27%
192,600
+96,300
+100% +$3.47M
INSP icon
93
Inspire Medical Systems
INSP
$1.42B
$7M 0.27%
+165,700
New +$7.04M
FICO icon
94
Fair Isaac
FICO
$23.2B
$6.99M 0.27%
37,400
+34,600
+1,236% +$6.75M
SIVB
95
DELISTED
SVB Financial Group
SIVB
$6.97M 0.27%
36,718
+26,818
+271% +$6.56M
ETFC
96
DELISTED
E*Trade Financial Corporation
ETFC
$6.97M 0.27%
158,767
+144,862
+1,042% +$7.1M
UNH icon
97
UnitedHealth
UNH
$378B
$6.95M 0.27%
27,900
+22,389
+406% +$5.91M
GTLS
98
DELISTED
Chart Industries
GTLS
$6.92M 0.27%
106,400
+101,700
+2,164% +$6.71M
ARYAU
99
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
$6.89M 0.27%
+666,500
New +$6.86M
AOS icon
100
A.O. Smith
AOS
$8.2B
$6.8M 0.26%
159,200
+118,509
+291% +$5.45M
2 3
4
5 6

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Schonfeld Strategic Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Schonfeld Strategic Advisors held 1,330 positions worth $2.6B, up 16% from $2.25B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Schonfeld Strategic Advisors deployed $870M of net new capital in Q4 2018, opening 552 new positions and adding to 277 existing holdings. Its largest new stake was Shire pic: 183,006 shares worth $31.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Fortive, an estimated $26.5M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2018 buy was Shire pic: 183,006 shares worth $31.8M.
  • Schonfeld Strategic Advisors added most to Plains GP Holdings in Q4 2018, an estimated $26.5M increase.
  • Schonfeld Strategic Advisors's biggest Q4 2018 reduction was Fortive, cutting an estimated $26.5M.
  • Schonfeld Strategic Advisors fully exited Churchill Capital Corp in Q4 2018, selling an estimated $20.3M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 13% of its $2.6B portfolio in Q4 2018.
  • Schonfeld Strategic Advisors opened 552 new positions and closed 296 in Q4 2018.
  • Schonfeld Strategic Advisors's portfolio value rose 16% quarter-over-quarter to $2.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.